( in Million)
Particulars
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
1377.2
1559.3
1313.3
1338.1
Total Expenditure
1498.9
1538.5
1419.2
1400.7
PBIDT (Excl OI)
-121.7
20.8
-105.9
-62.60
Other Income
8.9
8.8
7.7
33.1
Operating Profit
-112.8
29.59
-98.19
-29.5
Exceptional Items
NA
NA
-46
NA
PBDT
-161.9
-26.90
-214.7
-94.4
Depreciation
50.7
51.4
51.8
47
Profit Before Tax
-212.6
-78.30
-266.5
-141.4
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
-212.6
-73.90
-266.5
-141.4
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
-212.6
-73.90
-266.5
-141.4
Minority Interest
NA
NA
NA
NA
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
-212.6
-73.9
-266.5
-141.4
Equity Capital
167.4
167.4
167.4
167.4
Calculated EPS
-2.54
-0.88
-3.18
-1.68
Calculated EPS (Annualised)
-10.16
-3.53
-12.73
-6.75
No of Public Share Holdings
20961527
20961527
20960027
20960027
% of Public Share Holdings
25.04
25.04
25.04
25.04
PBIDTM% (Excl OI)
-8.83
1.33
-8.06
-4.67
PBIDTM%
-8.19
1.89
-7.47
-2.20
PBDTM%
-11.75
-1.72
-16.34
-7.05
PBTM%
-15.43
-5.02
-20.29
-10.56
PATM%
-15.43
-4.73
-20.29
-10.56